1. Home
  2. PD vs LXRX Comparison

PD vs LXRX Comparison

Compare PD & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PagerDuty Inc.

PD

PagerDuty Inc.

SELL

Current Price

$15.83

Market Cap

1.2B

Sector

Technology

ML Signal

SELL

LXRX

Lexicon Pharmaceuticals Inc.

SELL

Current Price

$1.81

Market Cap

996.7M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
PD
LXRX
Founded
2009
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
996.7M
IPO Year
2019
2000

Fundamental Metrics

Financial Performance
Metric
PD
LXRX
Price
$15.83
$1.81
Analyst Decision
Hold
Buy
Analyst Count
9
6
Target Price
★ $13.14
$4.52
AVG Volume (30 Days)
1.2M
★ 2.0M
Earning Date
11-27-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 416.95
77.78
EPS
★ 0.19
N/A
Revenue
★ $492,546,000.00
$49,803,000.00
Revenue This Year
$0.35
N/A
Revenue Next Year
$2.03
N/A
P/E Ratio
$83.92
★ N/A
Revenue Growth
5.36
★ 60.24
52 Week Low
$5.70
$1.10
52 Week High
$18.06
$2.68

Technical Indicators

Market Signals
Indicator
PD
LXRX
Relative Strength Index (RSI) 45.97 58.80
Support Level $6.08 $1.48
Resistance Level $17.81 $1.95
Average True Range (ATR) 0.60 0.11
MACD -0.21 0.05
Stochastic Oscillator 24.91 71.49

Price Performance

Historical Comparison
PD
LXRX

About PD PagerDuty Inc.

PagerDuty Inc is a digital operations management platform that manages urgent and mission-critical work for a modern, digital business. Its PagerDuty Operations Cloud combines artificial intelligence (AI) operations (AIOps), automation, customer service operations, and incident management with a generative AI assistant to create a flexible, resilient, and scalable platform to protect revenue and improve customer experience, improve operational efficiency, and mitigate the risk of operational failures. The company generates revenue predominantly from cloud-hosted software subscription fees and term-license software subscription fees. Geographically, the company derives a majority of its revenue from the United States and the rest from International markets.

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

Share on Social Networks: